Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Benitec Biopharm Ads (NASDAQ: BNTC)

$2.27 USD -$0.01 (-0.44%)
Last Price $2.27
Net Change $-0.01 (-0.44%)
Bid $2.26
Ask Price $2.32
Open Price $2.25
Previous Close Price $2.28
High Price $2.32
Low Price $2.25
Number of Trades 121
Volume 27,331
Fifty Two Week High $4.44 (2017-02-02)
Fifty Two Week Low $1.2 (2016-07-06)
Average Daily Volume 651,362
Share Outstanding 10,260 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $-0.28
Last Quarter EPS $
Market Capitalization $0.02B
Insider Shareholders % 0.056%
Annual Revenue $0B
No. Shares Outstanding 10,260
Inst. Shareholder % 3.08%
Annual Net Income $0B
TTM Net Profit Margin $100.03
1-Year Return 30.29%
3-Year Return -90.17%
5-Year Return -90.17%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio 1-4
Beta 3.36
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney Australia.

BNTC News & Stock Updates